Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)

Clinical trial NCT07629596 · RECRUITING

Trial details

NCT number: NCT07629596
Sponsor: Circunited BioPharma (Shenzhen) Co., Ltd.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Autoimmune Hemolytic Anemia (AIHA)

Start date: 2026-04-07
Primary completion: 2027-05-30
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.